OIA
MDGL icon

Optimum Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Optimum Investment Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-17
Closed -$2K – 1002
2014
Q3 		$2K Buy
+17
New +$2.37K ﹤0.01% 891

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Optimum Investment Advisors's MDGL Position: Q4 2014 in Review

Optimum Investment Advisors sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2014, closing a stake of 17 shares — an estimated $2K sold.

Optimum Investment Advisors first reported a position in MDGL in Q3 2014 and held it in 1 quarter. The position peaked at $2K in Q3 2014. 84 funds tracked by Wall St. Rank hold MDGL as of Q4 2014.

  • Optimum Investment Advisors reported no remaining Madrigal Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Optimum Investment Advisors sold 17 Madrigal Pharmaceuticals shares in Q4 2014, an estimated $2K.
  • Optimum Investment Advisors first reported a position in Madrigal Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Optimum Investment Advisors's Madrigal Pharmaceuticals position peaked at $2K in Q3 2014.
  • 84 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2014.

Based on Optimum Investment Advisors's 13F filing for Q4 2014, filed 12 Feb 2015.